RecruitingACTRN12625001214426

Effects of Social Robot-Based interventions in improving cognition, communication and social skills of children with Motor Movement Disorders (MMD)

Randomized controlled trial to evaluate the effect of Social Robot-Based interventions using QTRobot on cognition, communication, and social skills in children aged 5–12 years with cerebral palsy.


Sponsor

Ministry of Higher Education and Science

Enrollment

64 participants

Start Date

Sep 2, 2025

Study Type

Interventional

Conditions

Summary

This study aims to find out whether interacting with QTRobot can help improve thinking, communication, and social skills in children aged 5 to 12 with cerebral palsy. We believe that regular sessions with the robot-based interventions will support children’s development in these areas. The children will take part in individual sessions every other day a week for six to eight weeks at a rehabilitation center.


Eligibility

Sex: Both males and femalesMin Age: 5 YearssMax Age: 12 Yearss

Plain Language Summary

Simplified for easier understanding

Cerebral palsy is a condition that affects movement and muscle coordination. Children with cerebral palsy may also face challenges with thinking, communication, and social interaction. This study is exploring whether regular sessions with a social robot called QTRobot — a small, friendly humanoid robot designed to engage children in interactive activities — can help improve these skills in children aged 5 to 12 with spastic cerebral palsy. Children will take part in individual sessions with the robot every other day for six to eight weeks at a rehabilitation centre. The sessions are designed to be engaging and developmentally appropriate, targeting communication, cognitive skills, and social interaction. You may be eligible if your child is aged 5 to 12, has a diagnosis of spastic cerebral palsy (including hemiplegic, diplegic, or quadriplegic types), can follow simple verbal instructions, and is able to attend sessions regularly at the rehabilitation centre. Children with severe cognitive impairments, frequent epileptic seizures, or severe hearing or vision problems that would prevent interaction with the robot are not eligible.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Scripts and behavioural mapping: The robot uses pre-programmed scripts involving speech, emotional expressions (e.g. happy, sad, surprised), gestures (e.g. waving, nodding), and turn-taking prompts to

Scripts and behavioural mapping: The robot uses pre-programmed scripts involving speech, emotional expressions (e.g. happy, sad, surprised), gestures (e.g. waving, nodding), and turn-taking prompts to facilitate child–robot interaction. Games and tasks: Sessions include storytelling, object naming, emotion recognition, imitation of simple arm and leg movements, role-play dialogues, memory games, and turn-taking social tasks. Adherence monitoring: Attendance at each session will be recorded. The therapist will complete session checklists. Sessions will be video-recorded for fidelity checks. Where applicable, QTRobot usage metrics will be stored. Parental feedback will also be collected on engagement and participation. Frequency and duration: Each child will complete 10 sessions, 7-10 minutes each, delivered thrice per week over 4 weeks. Individualisation: Tasks will be adapted according to the child’s age, motor and cognitive level, and communication ability. Adjustments will be made by the therapist using QTRobot software (e.g. simpler vocabulary, shorter sentences, reduced motor complexity, or increased social challenge). Adaptations are made at the start of the program and updated as needed during sessions based on progress and therapist observation. Crossover and washout period: As this is a crossover trial, participants will first complete the QTRobot intervention, then after a washout period of 3 months, they will switch to the comparator/control condition (or vice versa, depending on randomisation). This period is intended to minimise carryover effects.


Locations(1)

ASTANA, Kazakhstan

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12625001214426